TY  - GEN
AU  - Amstutz,Ursula
AU  - Henricks,Linda M
AU  - Offer,Steven M
AU  - Barbarino,Julia
AU  - Schellens,Jan H M
AU  - Swen,Jesse J
AU  - Klein,Teri E
AU  - McLeod,Howard L
AU  - Caudle,Kelly E
AU  - Diasio,Robert B
AU  - Schwab,Matthias
TI  - Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update
SN  - 1532-6535
PY  - 2019///0409
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Capecitabine
KW  - Clinical Decision-Making
KW  - Dihydrouracil Dehydrogenase (NADP)
KW  - genetics
KW  - Drug Dosage Calculations
KW  - Fluorouracil
KW  - Genotype
KW  - Humans
KW  - Patient Selection
KW  - Pharmacogenetics
KW  - standards
KW  - Pharmacogenomic Testing
KW  - Pharmacogenomic Variants
KW  - Phenotype
KW  - Precision Medicine
KW  - Predictive Value of Tests
N1  - Publication Type: Journal Article; Practice Guideline; Systematic Review
UR  - https://doi.org/10.1002/cpt.911
ER  -